Urinalysis

Global Urinalysis Market to Reach US$5.4 Billion by 2030

The global market for Urinalysis estimated at US$4.0 Billion in the year 2024, is expected to reach US$5.4 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Urinalysis Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Urinalysis Instruments segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 8.9% CAGR

The Urinalysis market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Urinalysis Market - Key Trends & Drivers Summarized

What Is Urinalysis and Why Does It Matter?
Urinalysis is a diagnostic test that examines the physical, chemical, and microscopic properties of urine. This process is a cornerstone in medical diagnostics, providing insights into various aspects of a patient’s health. The test is non-invasive and straightforward, making it a preferred method for initial screening in many clinical settings. It helps detect a wide array of conditions, including urinary tract infections (UTIs), kidney diseases, diabetes, and liver problems. By analyzing elements such as pH, protein, glucose, ketones, and cells in the urine, healthcare providers can gain valuable information about a patient`s metabolic and systemic health. Urinalysis is not only utilized in routine check-ups but also in more specific situations, such as pre-surgical assessments, pregnancy monitoring, and management of chronic conditions.

How Has Technology Revolutionized Urinalysis?
The advancement in urinalysis technology has significantly enhanced the accuracy, efficiency, and scope of this diagnostic tool. Automation has played a crucial role, with the development of automated urine analyzers that can rapidly process large volumes of samples with minimal human intervention. These machines are equipped with advanced imaging and biochemical detection systems, enabling precise quantification and identification of various substances in the urine. Additionally, the integration of artificial intelligence and machine learning algorithms has allowed for more sophisticated analysis, such as pattern recognition in complex datasets, which can predict the onset of diseases earlier than traditional methods. The shift towards point-of-care testing (POCT) is another technological trend, where portable devices allow for quick urinalysis in various settings, including remote areas and home care, making healthcare more accessible and timely.

What Are the Key Applications and Uses of Urinalysis?
Urinalysis serves a broad spectrum of applications beyond basic health screening. In hospitals, it is a critical tool for monitoring the effectiveness of treatment in patients with chronic diseases, particularly those affecting the kidneys and liver. In occupational health, urinalysis is used for drug screening, detecting the presence of illicit substances, and ensuring workplace safety. Sports medicine also relies on urinalysis to monitor hydration levels and detect the use of performance-enhancing drugs. The veterinary field has similarly adopted urinalysis for diagnosing diseases in animals, making it a versatile tool across species. Moreover, research laboratories utilize urinalysis in clinical trials to evaluate the effects of new drugs and treatments on the human body. With its broad range of applications, urinalysis remains an indispensable tool in both clinical and research environments.

What Factors Are Driving the Growth of the Urinalysis Market?
The growth in the global urinalysis market is driven by several factors, reflecting the evolving needs and technological advancements in the healthcare industry. A significant driver is the rising prevalence of chronic diseases such as diabetes and kidney disorders, which necessitates regular monitoring and thus increases the demand for urinalysis. Technological innovations, such as the development of portable and automated urinalysis devices, have expanded the market by making testing more accessible and efficient. The growing trend of point-of-care diagnostics, fueled by the need for faster and more convenient testing, has also played a crucial role. Additionally, the aging population worldwide has led to an increased incidence of age-related diseases, further boosting the demand for urinalysis. The market is also benefiting from increased awareness and proactive health management among consumers, who are seeking regular screenings as part of preventive healthcare. Finally, the expansion of healthcare infrastructure in emerging economies is creating new opportunities for market growth, as more people gain access to diagnostic services.

SCOPE OF STUDY:

The report analyzes the Urinalysis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Consumables, Instruments); Application (Disease Diagnostics, Pregnancy Tests); End-Use (Hospitals & Clinical Laboratories, Diagnostics Laboratories, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 13 Featured) -

• 77 Elektronika Kft.
• ACON Laboratories, Inc.
• ARKRAY, Inc.
• AVE Science & Technology Co.Ltd
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Genrui Biotech
• Healthy.io
• Path Group Limited
• Quantimetrix

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.